Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.
about
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsCD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.The role of NKT cells in tumor immunityThe changes of CD4+CD25+/CD4+ proportion in spleen of tumor-bearing BALB/c miceThe role of pembrolizumab in the treatment of advanced non-small cell lung cancerThe impact of the myeloid response to radiation therapyFrom tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsRegulatory T cell: a protection for tumour cellsCombining radiation and immunotherapy: a new systemic therapy for solid tumors?Recent advance in antigen-specific immunotherapy for acute myeloid leukemiaInteraction between natural killer cells and regulatory T cells: perspectives for immunotherapySuppression, subversion and escape: the role of regulatory T cells in cancer progressionT-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune ResponsesFriend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphomaImmunosuppression associated with chronic inflammation in the tumor microenvironmentProspects for exosomes in immunotherapy of cancerMurine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cellsModification of the tumor microenvironment as a novel target of renal cell carcinoma therapeuticsRegulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbetaIn vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administrationImmunosuppressive strategies that are mediated by tumor cellsIL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes.Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapySimultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancerAn enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growIntensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells.The role of regulatory T cells in cancer.Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunityProtein kinase C-η controls CTLA-4-mediated regulatory T cell function.Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.Advanced malignant melanoma: immunologic and multimodal therapeutic strategiesVaccines against human carcinomas: strategies to improve antitumor immune responses.Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells.The impact of aging on cancer vaccination.Is cancer vaccination feasible at older age?Quantitative reconstruction of leukocyte subsets using DNA methylationDendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis.Natural regulatory T cells in malaria: host or parasite allies?Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma
P2860
Q24540135-9FA389D3-8115-4392-A623-8A927FBF85F7Q24540429-6372B2A9-47BB-4917-86E7-C338C1258A1FQ24648939-B4BA6B1A-BC42-417E-A4C4-F1D3FEA0C70DQ24805327-32AFEDC4-F446-4BF8-9816-3EE08F90BD38Q26744076-2C7BDCCD-E3A1-4E7C-89A8-B9B199256019Q26851643-65747E3C-8057-4DA8-A5DA-739EDD98175FQ26865532-F41206BE-5444-4754-BDA7-1AAE3D99560EQ26991447-EEDDDDA4-2E74-4F86-81A1-47734FEF9264Q26991721-910BE9F0-61D4-4F85-A814-5DA852730E79Q27005765-86C1675F-AD96-4ABE-B76C-D3736B850398Q27008625-A81EC755-CBA0-484C-A17F-5F0108698992Q27026151-CAD3A278-D19B-4B61-82E1-47A7088808D5Q27335110-12F802F7-F8D2-4FFA-B020-FC6D8C3E8983Q28067141-F4471491-3369-485F-9DA5-AE2D2F6CCF30Q28072320-53B667AC-0473-494D-86E1-60F0B77CCFF8Q28083450-8E102509-FCD7-4088-80D5-4DD862BEBAF6Q28248098-51A59F58-26AA-48F4-81AF-3E1655F01C0AQ28386617-E21AC4F8-54C7-42B6-95E0-CF291412408AQ28393614-A854C458-EC76-4A01-A571-0381702AE08EQ28475223-D6DE92D9-02FB-430B-A10A-3A3D045126DEQ28732675-5B476B21-F5C7-45CB-913C-DB236582E727Q29636247-2DC7D7F8-39FD-40DC-AADA-31676639D204Q30481064-3F8CA44A-9F19-4B34-BF41-FDD1AB09F764Q33282703-6DC10459-E8C3-450F-9B59-62F014192E5EQ33482453-068A46B5-A5E9-4DD5-8487-E86B8AE2CED8Q33598811-7FF7F036-D819-4F26-A068-0BB1FECD5306Q33629475-62D2E85F-9EE1-48BF-8426-6B5A29FA7DB3Q33631986-5DFFCEFB-4A2D-4107-B060-FFD47FE99EECQ33657130-B02438F3-92DF-4B91-8B16-0BBF7C821940Q33692966-3DECB9F5-B55C-4469-BCC3-24ECF8B195E3Q33707098-6D3FBF9E-C1CA-4862-9A9B-C2673A477224Q33717891-60992BC0-EC24-4706-8D9F-95A2DE40BA30Q33734281-23E5BD36-605B-4DF6-9CE2-F6BB4580026DQ33737660-801C0E40-2E64-4B86-8594-EDA4A9F1F05FQ33738706-C08071F3-DFDD-4463-890E-6340C37F044FQ33739907-813F4482-937A-40F5-84AC-048BA362B6E8Q33741592-EFDDC88C-6939-429A-9E26-DF69453F1E3DQ33756652-DAD13378-6F0E-485B-A856-40C9C96773D3Q33818748-DBCF42D8-CCB5-4FC7-A7FD-C56FF8AE4039Q33865610-BEFD29E8-6689-426E-9B98-9084C7EEF443
P2860
Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Induction of tumor immunity by ...... mor immunity and autoimmunity.
@ast
Induction of tumor immunity by ...... mor immunity and autoimmunity.
@en
Induction of tumor immunity by ...... mor immunity and autoimmunity.
@nl
type
label
Induction of tumor immunity by ...... mor immunity and autoimmunity.
@ast
Induction of tumor immunity by ...... mor immunity and autoimmunity.
@en
Induction of tumor immunity by ...... mor immunity and autoimmunity.
@nl
prefLabel
Induction of tumor immunity by ...... mor immunity and autoimmunity.
@ast
Induction of tumor immunity by ...... mor immunity and autoimmunity.
@en
Induction of tumor immunity by ...... mor immunity and autoimmunity.
@nl
P2093
P1476
Induction of tumor immunity by ...... mor immunity and autoimmunity.
@en
P2093
Sakaguchi S
Yamazaki S
P304
P407
P577
1999-11-01T00:00:00Z